Derek P Chew1, Christopher Zeitz2, Matthew Worthley2, Hugh Grantham2, John Beltrame2, Margaret Arstall2, Penelope Coates2, Carolyn Astley2, Stephen Quinn2, Julie Ratcliffe2, Matthew Horsfall2, Philip G Aylward2. 1. From the Flinders University, Adelaide, South Australia, Australia (D.P.C., H.G., C.A., S.Q., J.R., P.G.A.); Flinders Medical Centre, Adelaide, South Australia, Australia (D.P.C., P.G.A.); University of Adelaide, Adelaide, South Australia, Australia (C.Z., M.W., J.B.); The Royal Adelaide Hospital, Adelaide, South Australia, Australia (C.Z., M.W.); The Queen Elizabeth Hospital, Adelaide South Australia, Australia (J.B.); The Lyell McEwen Hospital, Adelaide, South Australia, Australia (M.A.); SA Pathology, SA Health Adelaide, South Australia, Australia (P.C.); Heart Foundation, South Australia, Australia (C.A.); and SA Health, Adelaide, Australia (M.H.). derek.chew@flinders.edu.au. 2. From the Flinders University, Adelaide, South Australia, Australia (D.P.C., H.G., C.A., S.Q., J.R., P.G.A.); Flinders Medical Centre, Adelaide, South Australia, Australia (D.P.C., P.G.A.); University of Adelaide, Adelaide, South Australia, Australia (C.Z., M.W., J.B.); The Royal Adelaide Hospital, Adelaide, South Australia, Australia (C.Z., M.W.); The Queen Elizabeth Hospital, Adelaide South Australia, Australia (J.B.); The Lyell McEwen Hospital, Adelaide, South Australia, Australia (M.A.); SA Pathology, SA Health Adelaide, South Australia, Australia (P.C.); Heart Foundation, South Australia, Australia (C.A.); and SA Health, Adelaide, Australia (M.H.).
Abstract
BACKGROUND:High-sensitivity troponin T (hs-TnT) assays promise greater discrimination of evolving myocardial infarction, but the impact of unguided implementation on the effectiveness of care is uncertain. METHODS AND RESULTS: We evaluated the impact of hs-TnT reporting on care and outcome among chest pain patients presenting to 5 emergency departments within a multicenter randomized trial. Patients were allocated to hs-TnT reporting (hs-report) or standard reporting (std-report; Roche Elecys). The primary end point was death and new or recurrent acute coronary syndrome by 12 months. A total of 1937 patients without ST-segment elevation were enrolled between July 2011 and March 2013. The median age was 61 (interquartile range, 48-74) years, and 46.3% were women. During the index hospitalization, 1466 patients (75.7%) had maximal troponin <30 ng/L within 24 hours. Randomization to hs-report format did not alter the admission rate (hs-report: 57.7% versus std-report: 58.0%; P=0.069). There was no difference in angiography (hs-report: 11.9% versus std-report: 10.9%; P=0.479). The hs-reporting did not reduce 12-month death or new/recurrent acute coronary syndrome in the overall population (hs-report: 9.7% versus std-report: 7.2% [hazard ratio, 0.83 (0.57-1.22); P=0.362]). However, among those with troponin levels <30 ng/L, a modest reduction in the primary end point was observed (hs-report: 2.6% versus std-report: 4.4%, [hazard ratio, 0.58; 95% confidence interval, 0.34-0.1.00; P=0.050). CONCLUSIONS:High-sensitivity troponin reporting alone is associated with only modest changes in practice. Clinical effectiveness in the adoption of high-sensitivity troponin may require close coupling with protocols that guide interpretation and care. CLINICAL TRIAL REGISTRATION: URL: http://www.ANZCTR.org.au. Unique identifier: ACTRN12611000879965.
RCT Entities:
BACKGROUND: High-sensitivity troponin T (hs-TnT) assays promise greater discrimination of evolving myocardial infarction, but the impact of unguided implementation on the effectiveness of care is uncertain. METHODS AND RESULTS: We evaluated the impact of hs-TnT reporting on care and outcome among chest painpatients presenting to 5 emergency departments within a multicenter randomized trial. Patients were allocated to hs-TnT reporting (hs-report) or standard reporting (std-report; Roche Elecys). The primary end point was death and new or recurrent acute coronary syndrome by 12 months. A total of 1937 patients without ST-segment elevation were enrolled between July 2011 and March 2013. The median age was 61 (interquartile range, 48-74) years, and 46.3% were women. During the index hospitalization, 1466 patients (75.7%) had maximal troponin <30 ng/L within 24 hours. Randomization to hs-report format did not alter the admission rate (hs-report: 57.7% versus std-report: 58.0%; P=0.069). There was no difference in angiography (hs-report: 11.9% versus std-report: 10.9%; P=0.479). The hs-reporting did not reduce 12-month death or new/recurrent acute coronary syndrome in the overall population (hs-report: 9.7% versus std-report: 7.2% [hazard ratio, 0.83 (0.57-1.22); P=0.362]). However, among those with troponin levels <30 ng/L, a modest reduction in the primary end point was observed (hs-report: 2.6% versus std-report: 4.4%, [hazard ratio, 0.58; 95% confidence interval, 0.34-0.1.00; P=0.050). CONCLUSIONS: High-sensitivity troponin reporting alone is associated with only modest changes in practice. Clinical effectiveness in the adoption of high-sensitivity troponin may require close coupling with protocols that guide interpretation and care. CLINICAL TRIAL REGISTRATION: URL: http://www.ANZCTR.org.au. Unique identifier: ACTRN12611000879965.
Authors: Ziwei Lin; Swee Han Lim; Siang Jin Terrance Chua; E Shyong Tai; Yiong Huak Chan; Arthur Mark Richards Journal: Singapore Med J Date: 2019-02-18 Impact factor: 1.858
Authors: Marc A Probst; Thomas A Gibson; Robert E Weiss; Annick N Yagapen; Susan E Malveau; David H Adler; Aveh Bastani; Christopher W Baugh; Jeffrey M Caterino; Carol L Clark; Deborah B Diercks; Judd E Hollander; Bret A Nicks; Daniel K Nishijima; Manish N Shah; Kirk A Stiffler; Alan B Storrow; Scott T Wilber; Benjamin C Sun Journal: J Hosp Med Date: 2018-09-26 Impact factor: 2.960
Authors: Kiril M Stoyanov; Hauke Hund; Moritz Biener; Jochen Gandowitz; Christoph Riedle; Julia Löhr; Matthias Mueller-Hennessen; Mehrshad Vafaie; Hugo A Katus; Evangelos Giannitsis Journal: Eur Heart J Acute Cardiovasc Care Date: 2019-07-12
Authors: Venkatesh Thiruganasambandamoorthy; Ian G Stiell; Hina Chaudry; Muhammad Mukarram; Ronald A Booth; Cristian Toarta; Guy Hebert; Robert S Beanlands; George A Wells; Marie-Joe Nemnom; Monica Taljaard Journal: PLoS One Date: 2020-01-10 Impact factor: 3.240
Authors: Ziwei Lin; Swee Han Lim; Qai Ven Yap; Carol Hui Chen Tan; Yiong Huak Chan; Hung Chew Wong; E Shyong Tai; Arthur Mark Richards; Terrance Siang Jin Chua Journal: Int J Cardiol Heart Vasc Date: 2021-03-25